Controversial blood testing organization Theranos is going on the offensive in the wake of an apparent second regulatory rebuke and finding itself at the center of slight controversy involving the presidential bid of Hillary Clinton.
The company announced the expansion of medical advisory board to address what a spokesperson said was its key problem: management and leadership oversight. Against this background the $9 billion medical start-up clarified its involvement in a recent fund raising event involving Elizabeth Homes and Chelsea Clinton.
Theranos new offensive: We never intended to host the Clinton event, just one friend helping another
Theranos never planned on using company funds or assets to host a fundraiser for Democratic Presidential front-runner Hillary Clinton. The fundraiser was initially announced...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
